155 related articles for article (PubMed ID: 37779078)
21. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
[TBL] [Abstract][Full Text] [Related]
22. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis.
Li C; Yang J; Lei S; Wang W
Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155
[TBL] [Abstract][Full Text] [Related]
23. IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/β-catenin pathway.
Chen KC; Chen PH; Ho KH; Shih CM; Chou CM; Cheng CH; Lee CC
PLoS One; 2019; 14(12):e0225913. PubMed ID: 31805126
[TBL] [Abstract][Full Text] [Related]
24. FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β-catenin nuclear accumulation.
Xu K; Zhang Z; Pei H; Wang H; Li L; Xia Q
Oncol Rep; 2017 Apr; 37(4):2391-2397. PubMed ID: 28260024
[TBL] [Abstract][Full Text] [Related]
25. Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma.
Kitabayashi T; Dong Y; Furuta T; Sabit H; Jiapaer S; Zhang J; Zhang G; Hayashi Y; Kobayashi M; Domoto T; Minamoto T; Hirao A; Nakada M
Sci Rep; 2019 Jul; 9(1):10049. PubMed ID: 31296906
[TBL] [Abstract][Full Text] [Related]
26. Circ
Li J; Ma J; Huang S; Li J; Zhou L; Sun J; Chen L
Mol Cell Biol; 2023; 43(7):354-369. PubMed ID: 37427890
[TBL] [Abstract][Full Text] [Related]
27. The A-Kinase Anchoring Protein (AKAP) Glycogen Synthase Kinase 3β Interaction Protein (GSKIP) Regulates β-Catenin through Its Interactions with Both Protein Kinase A (PKA) and GSK3β.
Dema A; Schröter MF; Perets E; Skroblin P; Moutty MC; Deàk VA; Birchmeier W; Klussmann E
J Biol Chem; 2016 Sep; 291(37):19618-30. PubMed ID: 27484798
[TBL] [Abstract][Full Text] [Related]
28. RNF6 promotes colorectal cancer invasion and migration via the Wnt/β-catenin pathway by inhibiting GSK3β activity.
Li Q; Wang G; Tao J; Chen W
Pathol Res Pract; 2021 Sep; 225():153545. PubMed ID: 34352441
[TBL] [Abstract][Full Text] [Related]
29. Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide.
Majchrzak-Celińska A; Kleszcz R; Studzińska-Sroka E; Łukaszyk A; Szoszkiewicz A; Stelcer E; Jopek K; Rucinski M; Cielecka-Piontek J; Krajka-Kuźniak V
Cells; 2022 Mar; 11(7):. PubMed ID: 35406647
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
Tian T; Mingyi M; Qiu X; Qiu Y
Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996
[TBL] [Abstract][Full Text] [Related]
31. RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway.
Sun J; Ma Q; Li B; Wang C; Mo L; Zhang X; Tang F; Wang Q; Yan X; Yao X; Wu Q; Shu C; Xiong J; Fan W; Wang J
Cell Death Dis; 2020 Oct; 11(10):890. PubMed ID: 33087705
[TBL] [Abstract][Full Text] [Related]
32. Loss of PKCδ Induces Prostate Cancer Resistance to Paclitaxel through Activation of Wnt/β-Catenin Pathway and Mcl-1 Accumulation.
Flores ML; Castilla C; Gasca J; Medina R; Pérez-Valderrama B; Romero F; Japón MA; Sáez C
Mol Cancer Ther; 2016 Jul; 15(7):1713-25. PubMed ID: 27196755
[TBL] [Abstract][Full Text] [Related]
33. Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways.
Bagherian A; Mardani R; Roudi B; Taghizadeh M; Banfshe HR; Ghaderi A; Davoodvandi A; Shamollaghamsari S; Hamblin MR; Mirzaei H
J Mol Neurosci; 2020 Oct; 70(10):1471-1483. PubMed ID: 32666415
[TBL] [Abstract][Full Text] [Related]
34. miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway.
Liu S; Wang Q; Liu Y; Xia ZY
J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502580
[TBL] [Abstract][Full Text] [Related]
35. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
36. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.
Chung J; Karkhanis V; Baiocchi RA; Sif S
J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941
[TBL] [Abstract][Full Text] [Related]
37. 5-lipoxygenase as a target to sensitize glioblastoma to temozolomide treatment via β-catenin-dependent pathway.
Tang D; Hu Y; Gao W
Neurol Res; 2023 Nov; 45(11):1026-1034. PubMed ID: 37695758
[TBL] [Abstract][Full Text] [Related]
38. Role of Sonic hedgehog signaling in cell cycle, oxidative stress, and autophagy of temozolomide resistant glioblastoma.
Honorato JR; Hauser-Davis RA; Saggioro EM; Correia FV; Sales-Junior SF; Soares LOS; Lima LDR; Moura-Neto V; Lopes GPF; Spohr TCLS
J Cell Physiol; 2020 Apr; 235(4):3798-3814. PubMed ID: 31613002
[TBL] [Abstract][Full Text] [Related]
39. Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.
Furuta T; Sabit H; Dong Y; Miyashita K; Kinoshita M; Uchiyama N; Hayashi Y; Hayashi Y; Minamoto T; Nakada M
Oncotarget; 2017 Apr; 8(14):22811-22824. PubMed ID: 28423558
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and contributes to poor patient prognosis.
Patil SS; Gokulnath P; Bashir M; Shwetha SD; Jaiswal J; Shastry AH; Arimappamagan A; Santosh V; Kondaiah P
Neuro Oncol; 2016 Nov; 18(11):1487-1497. PubMed ID: 27044294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
